Abstract
ABSTRACTA pre-filled syringe for the long-term, room-temperature storage and injection of vaccines is described. Stabilisation was achieved by drying from a trehalose-containing buffer which formed an inert soluble glass distributed in the internal interconnected voids in a compliant reticulated medical-grade sponge. The sponge is stored inside the barrel of the syringe and the vaccines are re-solubilised by the aspiration of water. The syringe contains the sponge throughout the filling and drying processes in manufacture, and in transport, stockpiling and finally injection. The active vaccine is delivered to the patient in the normal injection process by depressing the plunger, which compresses the sponge to completely expel the dose. There was full recovery of vaccine potency, after 7-10 months @ 45°C, as shown by complete protection against active toxins in immunised Guinea pigs.
Publisher
Cold Spring Harbor Laboratory
Reference33 articles.
1. WHO 2019 NCoV UCC Systems Pfizer BioNTech Vaccine 2022.1 Eng | PDF, (n.d.). https://es.scribd.com/document/559688399/WHO-2019-NCoV-UCC-Systems-Pfizer-BioNTech-Vaccine-2022-1-Eng (accessed August 31, 2022).
2. Monitoring vaccine wastage at country level Guidelines for programme managers Immunization, Vaccines and Biologicals, 2005. https://apps.who.int/iris/handle/10665/68463 (accessed September 8, 2022).
3. A vaccine cold chain temperature monitoring study in the United Mexican States;Vaccine,2020
4. Vaccine stabilization: Research, commercialization, and potential impact;Vaccine,2011
5. Freezing temperatures in the vaccine cold chain: A systematic literature review